glp-1 medications after bariatric surgery and called GLP-1s (glucagon-like peptide-1 receptor agonists) are popular options for treating obesity. Learn about these two treatment approaches and their effectiveness at achieving weight loss goals Bariatric Surgery vs. GLP-1 Medications:

Retatrutide should be considered a second-line or specialized first-line agent for complex cases once it gains regulatory approval

We currently support Zepbound and Wegovy for obesity and related co-morbidities, and Ozempic, Mounjaro, and Rybelsus for type 2 diabetes

Understanding Protein-Based Medication Storage A comprehensive 2023 Cochrane systematic review on insulin thermal stability provides additional context relevant to all protein-based injectable medications, including GLP-1s

Therapeutic peptides: historical perspectives, current development trends, and future directions

Each method has its unique benefits and considerations